# Nycrist Pharmatech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nycrist-pharmatech

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Website: www.nycrist.com
- Latest round: Series A (Jan 10, 2018)
- Investors on record: 1

## About

Established in 2015 and based in Shenzhen, China, Nycrist Pharmatech Limited is a company that focuses on the research and development of preclinical drugs. In July 2018, the firm closed an angel funding. The company has a research and development platform and production line of more than 6,000 square meters, including a crystal drug research and development laboratory (CRO), small-scale and pilot laboratories for new drug development, etc.

The company's main products include solid preparations, oral film preparations and topical preparations. Its products are used in conditions such as schizophrenia, skin infections and leukemia.

The company’s revenue is generated by providing solid preparations, oral film preparations and topical preparations.

## Funding rounds

- Series A, Jan 10, 2018 — KCH Capital Management

## Investors

- KCH Capital Management (https://capitalatlas.ai/funds/kch-capital-management) — Series A